Doug Mers is a Program Manager specializing in biologics and technical operations with over 25 years of experience in GMP clinical and commercial manufacturing. Currently, Doug serves as the Program Manager and Bulk Drug Substance SME at Verta Life Sciences, focusing on late-stage monoclonal antibody production and regulatory submissions. Previously, Doug held various roles at Amgen, demonstrating expertise in cell culture and process optimization, and has also worked as a Managing Partner at 2M Consulting, offering insights into biopharmaceutical manufacturing. Doug earned a Bachelor of Science in Biological and Biomedical Sciences from the University of California, Irvine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices